Inhibition activities of natural products on serine proteases

被引:56
作者
Jedinák, A
Maliar, T
Grancai, D
Nagy, M
机构
[1] Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83534, Slovakia
[2] VULM As, Modra 90001, Slovakia
[3] Univ SS Cyril & Methodius Trnava, Trnava 91701, Slovakia
[4] Comenius Univ, Fac Pharm, Dept Pharmacognosy & Bot, Bratislava 83232, Slovakia
关键词
flavonoid; phenolics; urokinase; thrombin; trypsin;
D O I
10.1002/ptr.1836
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Proteases play a key role in a variety of pathologies, including cancer, pancreatitis and thrombosis. Low molecular inhibitors can act as drugs to combat these pathologies. Twelve natural phenolic compounds and one alkaloid were evaluated. Quercetin was used as a standard in the in vitro tests on serine proteases (trypsin, thrombin and urokinase). Salicin showed a highly selective effect with a value of IC50 = 11.4 mu m for thrombin, suggesting it may be a suitable lead structure for developing thrombin inhibitors and thus for perspective thrombolytics. Interesting results were also observed for hyperoside with IC50 = 8.3 mu m for urokinase. The flavonoid skeleton seems to be a suitable structure for investigating urokinase inhibitors as prospective drugs for cancer therapy. A very high inhibitory activity on trypsin was observed for the flavonoid silybin (IC50 = 3.7 mu m), indicating a prospective structure on which to base possible polyphenolic trypsin inhibitors. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:214 / 217
页数:4
相关论文
共 11 条
  • [1] Natural products in drug discovery and development
    Cragg, GM
    Newman, DJ
    Snader, KM
    [J]. JOURNAL OF NATURAL PRODUCTS, 1997, 60 (01): : 52 - 60
  • [2] da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364
  • [3] PREPARATION AND PROPERTIES OF 2 NEW CHROMOGENIC SUBSTRATES OF TRYPSIN
    ERLANGER, BF
    COHEN, W
    KOKOWSKY, N
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1961, 95 (02) : 271 - &
  • [4] Frecer V., 2000, INT J MED BIOL ENV, V28, P161
  • [5] Grabley S, 1999, Adv Biochem Eng Biotechnol, V64, P101
  • [6] Structural aspects of flavonoids as trypsin inhibitors
    Maliar, T
    Jedinák, A
    Kadrabová, J
    Sturdík, E
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (03) : 241 - 248
  • [7] Advances in cancer therapy with plant based natural products
    Mukherjee, AK
    Basu, S
    Sarkar, N
    Ghosh, AC
    [J]. CURRENT MEDICINAL CHEMISTRY, 2001, 8 (12) : 1467 - 1486
  • [8] SYNTHETIC SUBSTRATES AND DISCRIMINATION BETWEEN UROKINASE AND TISSUE PLASMINOGEN ACTIVATOR ACTIVITY
    NIEUWENHUIZEN, W
    WIJNGAARDS, G
    GROENEVELD, E
    [J]. THROMBOSIS RESEARCH, 1977, 11 (01) : 87 - 89
  • [9] Aspartic protease inhibitors -: An integrated approach for the design and synthesis of diaminodiol-based peptidomimetics
    Tossi, A
    Bonin, I
    Antcheva, N
    Norbedo, S
    Benedetti, F
    Miertus, S
    Nair, AC
    Maliar, T
    Dal Bello, F
    Palù, G
    Romeo, D
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (06): : 1715 - 1722
  • [10] Wang Y, 2001, MED RES REV, V21, P146, DOI 10.1002/1098-1128(200103)21:2<146::AID-MED1004>3.0.CO